Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

ADDvance Pharma in Scandinavia AB

Closing information (x1000 EUR)

Closing information 2024/08 2023/08 2022/08
Turnover 1,842 Less Arrow 1,704 Less Arrow 1,272
Financial expenses 1 Less Arrow 0 More Arrow 8
Earnings before taxes 402 Less Arrow 353 Less Arrow 140
EBITDA 389 Less Arrow 339 Less Arrow 148
Total assets 1,090 Less Arrow 970 Less Arrow 759
Current assets 767 More Arrow 780 Less Arrow 692
Current liabilities 211 More Arrow 442 Less Arrow 260
Equity capital 823 Less Arrow 485 Less Arrow 452
- share capital 9 Less Arrow 8 More Arrow 9
Employees (average) 2 Equal arrow 2 Equal arrow 2

Financial ratios

Fiscal year 2024/08 2023/08 2022/08
Solvency 75.5% Less Arrow 50.0% More Arrow 59.6%
Turnover per employee 921 Less Arrow 852 Less Arrow 636
Profit as a percentage of turnover 21.8% Less Arrow 20.7% Less Arrow 11.0%
Return on assets (ROA) 37.0% Less Arrow 36.4% Less Arrow 19.5%
Current ratio 363.5% Less Arrow 176.5% More Arrow 266.2%
Return on equity (ROE) 48.8% More Arrow 72.8% Less Arrow 31.0%
Change turnover 61 More Arrow 557 Less Arrow 38
Change turnover % 3% More Arrow 49% Less Arrow 3%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/08 2023/08 2022/08
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.